Trials / Completed
CompletedNCT01640197
Chronic Resveratrol Supplementation in Healthy Humans
The Effects of Chronic Trans- Resveratrol Supplementation on Aspects of Cognitive Performance, Mood, Sleep, Health and Cerebral Blood Flow in Healthy, Young Humans.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Northumbria University · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The effects of chronic resveratrol supplementation have yet to be investigated in healthy humans. It is hypothesised that the effects will be different to those seen in acute supplementation. This study will look specifically at cognitive performance, cerebral blood flow, subjective sleep, mood and health, blood pressure and plasma levels of resveratrol. It is hypothesized that these measures will be affected differently by acute and chronic supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Resveratrol | Transmax (Biotivia). 500mg (1 capsule) per day for 28 days. |
| OTHER | Placebo | Methyl Cellulose. 1 capsule taken once daily for 28 days. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-07-13
- Last updated
- 2012-10-19
- Results posted
- 2012-10-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01640197. Inclusion in this directory is not an endorsement.